Tom Valentino

News

NIH-Backed Study to Evaluate Mobile Clinics for Integrated HIV, SUD Treatment

06/16/2021

A new clinical trial will look to determine whether delivering integrated services at mobile clinics can improve both HIV and substance use outcomes among individuals with opioid use disorder who inject drugs.

A new clinical trial will look...

06/16/2021

Addiction Professional

News

Long-time Hazelden Chief Medical Officer to Retire

07/21/2021

Tom Valentino ;

Hazelden Betty Ford Foundation chief medical officer Marvin Seppala, MD, who played a key role in the development of the organization’s nationally recognized COR-12 (Comprehensive Opioid Response with the 12 Steps) program, plans to retire...

Hazelden Betty Ford Foundation...

07/21/2021

Behavioral Healthcare Executive

News

NIDA Awards $2.5 Million for Study of App to Augment MAT

08/24/2021

Tom Valentino ;

NIDA has awarded a 5-year, $2.5 million grant to research scientists at the University of Arkansas for Medical Sciences to study whether a cell phone app can reduce relapses rates in individuals with opioid use disorder.

NIDA has awarded a 5-year, $2.5...

08/24/2021

Addiction Professional

News

Dreamscape Marketing Joins SPM Group

09/15/2021

Tom Valentino ;

Dreamscape Marketing, a Maryland-based digital marketing firm that specializes in working with clients in the healthcare sector, has joined SPM Group, a Chicago-based firm anchored by the integrated marketing and communications firm SPM.

Dreamscape Marketing, a...

09/15/2021

Behavioral Healthcare Executive

News

Psychedelics Briefs: Numinus Wellness, Awakn Life Sciences

10/21/2021

Tom Valentino ;

Numinus Wellness has finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived psilocybin extract, while an Awakn Life Sciences facility in the UK has received a key approval to begin offering...

Numinus Wellness has finalized...

10/21/2021

Behavioral Healthcare Executive

News

Yalom Sees Formula for Helping Patients Address ‘Death Anxiety’

12/01/2021

Tom Valentino ;

In an Evolution of Psychotherapy keynote interview, Irv Yalom, MD, professor emeritus of psychiatry at the Stanford University School of Medicine, said helping patients find ways to work toward a regret-free life can help lessen the burden of...

In an Evolution of Psychotherapy...

12/01/2021

Psych Congress Network

News

Psychedelics Briefs: Numinus, Pacific Neuroscience Institute, Delix

01/14/2022

Tom Valentino ;

Numinus Wellness and Pacific Neuroscience Institute have announced developments around clinical trials, while Delix Therapeutics has secured new funding to expand its operations.

Numinus Wellness and Pacific...

01/14/2022

Behavioral Healthcare Executive

News

Bill to Protect Providers’ Mental Health Gets Congressional Approval

02/28/2022

Tom Valentino ;

The Dr. Lorna Breen Health Care Provider Protection Act, legislation that supports the mental and behavioral health of healthcare providers, has been unanimously approved by the US Senate, and is expected to be signed into law by President...

The Dr. Lorna Breen Health Care...

02/28/2022

Behavioral Healthcare Executive

News

Numinus to Acquire Novamind in Significant Psychedelic Therapy and Research Deal

04/12/2022

Tom Valentino ;

Numinus Wellness has entered into an agreement to acquire Novamind in a $26.2 million ($20.77 million US) deal announced by the 2 companies on Tuesday morning.

Numinus Wellness has entered...

04/12/2022

Behavioral Healthcare Executive

News

Millennium Health, University of Cincinnati to Study Precipitated Withdrawal During Buprenorphine Induction

05/14/2022

Tom Valentino ;

The findings could help clinicians identify risk factors for precipitated withdrawal during buprenorphine induction and inform future treatment approaches.

The findings could help...

05/14/2022

Addiction Professional